Hosted on MSN13d
Eli Lilly Lowers Cost of Zepbound Vials to Attract People Without Insurance CoverageEli Lilly announced Tuesday that it is selling higher-dose vials of Zepbound at lower prices in its direct-to-consumer ...
After scoring a long-awaited FDA approval last fall, Eli Lilly has launched a consumer-facing campaign to get the word out ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results